1. Treatment of CF exacerbations based on multiple combination antibiotic susceptibility testing-a randomized, double-blind, controlled clinical trial;Aaron;Pediatric Pulmonolgy,2005
2. Combination antibiotic susceptibility testing to treat exacerbations of cystic fibrosis associated with multiresistant bacteria: a randomized, double-blind, controlled clinical trial;Aaron;Lancet,2005
3. Evaluation of the efficacy of antibiotic treatments associated with the Nebcine® as intravenous injection only and / or monitoring of aerosols of Tobi® in order to optimize the therapeutic management of exacerbations in patients with cystic fibrosis apps.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2014-003882-10-FR
4. What duration of intravenous antibiotic therapy should be used in the treatment of infective exacerbations of cystic fibrosis in patients chronically colonised with Pseudomonas aeruginosa? - Duration of antibiotics in infective exacerbations of cystic fibrosis apps.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2009-014042-28-GB
5. Duration of antibiotics in infective exacerbations of cystic fibrosis clinicaltrials.gov/show/NCT01044719